Fitch Ratings
Credit agencies lower Medtronic’s rating post-Covidien merger
Fitch affirms Boston Scientific’s bond rating
New J&J CEO Gorsky wants to grow device business | Wall Street Beat
When Alex Gorsky takes the helm at Johnson & Johnson (NYSE:JNJ) tomorrow, he’ll become responsible for a company bedeviled by a series of high-profile, big-ticket recalls, a more than $1 billion legal settlement – and blessed with the world’s largest medical device business.